Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships

University of Alberta

$70,000.00

The role of small intestinal permeability in the pathogenesis of colitis.

EF 2008-09

Résumé
Intestinal bowel disease (IBD) comprises Crohn's disease and colitis and it affects one in every 350 Canadians, one of the highest incidences in the world. The cause of IBD remains unknown. However, it appears that three critical features must be present for disease to occur. First are the environmental factors, like the bacterial flora, as the disease does not occur in predisposed animal models under germ free conditions. A genetic component appears to be also required and several gene mutations have been identified. Lastly, it is evident that increased small intestinal permeability or leakiness is commonly observed in human populations at high risk of developing Crohn's disease. In three animal models of Crohn's disease, it has now been convincingly demonstrated that abnormal intestinal permeability is present prior to the disease. Taken together, these observations suggest that IBD may develop as a consequence of abnormally leaky small intestine, which allows increased presentation of the intestinal bacterial to a genetically predisposed organism. However, it is still a matter of much debate whether the permeability defect is the prime initiating factor for the development of disease or not. The goal of my thesis is to define this cause-effect relationship. Recent discoveries have allowed for the creation of drugs that regulate intestinal permeability. These agents can be used to establish whether increased permeability is a necessary prerequisite for the development of disease. They can also be used to determine whether correcting the intestinal permeability defect will prevent or attenuate disease. One of these drugs has been tried in the BBrat, an animal model of diabetes and was found to be effective in preventing systemic inflammation. My proposed research with similar agents will allow me to determine whether a similar strategy could be useful for IBD as well.
Programme
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
184482
Name
Arrieta Mendez Marie-Claire
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Nutrition, Metabolism and Diabetes
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
The role of small intestinal permeability in the pathogenesis of colitis.
Programtype2
Studentship Programs
Orgnameinp2
University of Alberta
Cihramount2
$70,000
Cihrequipment2
$0
Programname2
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Keyworddelim
Colitis; Flow Cytometry; Intestinal Permeability; Ion Exchange Chromatography; Mucosal Immunology; Oral Tolerance; T Cell Proliferation; Ussing Chambers
Abstract
Intestinal bowel disease (IBD) comprises Crohn's disease and colitis and it affects one in every 350 Canadians, one of the highest incidences in the world. The cause of IBD remains unknown. However, it appears that three critical features must be present for disease to occur. First are the environmental factors, like the bacterial flora, as the disease does not occur in predisposed animal models under germ free conditions. A genetic component appears to be also required and several gene mutations have been identified. Lastly, it is evident that increased small intestinal permeability or leakiness is commonly observed in human populations at high risk of developing Crohn's disease. In three animal models of Crohn's disease, it has now been convincingly demonstrated that abnormal intestinal permeability is present prior to the disease. Taken together, these observations suggest that IBD may develop as a consequence of abnormally leaky small intestine, which allows increased presentation of the intestinal bacterial to a genetically predisposed organism. However, it is still a matter of much debate whether the permeability defect is the prime initiating factor for the development of disease or not. The goal of my thesis is to define this cause-effect relationship. Recent discoveries have allowed for the creation of drugs that regulate intestinal permeability. These agents can be used to establish whether increased permeability is a necessary prerequisite for the development of disease. They can also be used to determine whether correcting the intestinal permeability defect will prevent or attenuate disease. One of these drugs has been tried in the BBrat, an animal model of diabetes and was found to be effective in preventing systemic inflammation. My proposed research with similar agents will allow me to determine whether a similar strategy could be useful for IBD as well.
Competitiondate
200810
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Arrieta Mendez, Marie-Claire
Approvedterm
2 ans 0 mois
Cihrcontribution2
~ $70,000~ $0~